The 2014 East User Group Meeting's invited speaker presentations: Cytel's own Jim Bolognese reveals recent experiences with Phase 2 adaptive dose-finding designs that efficiently "assign more subjects to the correct dose" to more effectively examine the effects of the best-performing dose level.
See all the 2014 speakers / titles at:
[ Ссылка ]...
2014 EUGM - Innovating Clinical Trials. Together.
www.cytel.com
+1 .617.661.2011
